Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new history entry was added for Study Status with Revision v3.5.2 (dated 2026-04-13), and the prior Revision v3.5.0 was removed (dated 2026-03-12).SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedA new version entry dated 2026-03-12 for Study Status (revision v3.5.0) was added to the history, and the prior 2026-02-13 revision (v3.4.3) was removed.SummaryDifference0.2%

- Check46 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed in the page history. This is a system version update rather than a change to trial data.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded a new 2026-02-13 entry for Study Status in the record history. A deletion dated 2026-01-16 is also shown.SummaryDifference0.2%

- Check74 days agoChange DetectedAdded a new revision entry (v3.4.2) to the page history, and the prior funding-lapse notice and v3.4.1 revision were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check81 days agoChange DetectedThe only visible changes are a site-wide funding notice and revision updates (v3.4.1 replacing v3.4.0), which do not affect trial data or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.